DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
出版年份 2021 全文链接
标题
DNA Methylation of PI3K/AKT Pathway-Related Genes Predicts Outcome in Patients with Pancreatic Cancer: A Comprehensive Bioinformatics-Based Study
作者
关键词
-
出版物
Cancers
Volume 13, Issue 24, Pages 6354
出版商
MDPI AG
发表日期
2021-12-20
DOI
10.3390/cancers13246354
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression
- (2021) Aamir Ali Khan et al. CANCER AND METASTASIS REVIEWS
- Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer
- (2021) Vladimir V. Strelnikov et al. Scientific Reports
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of DNA methylation‑driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma
- (2020) Wei Zhang et al. Experimental and Therapeutic Medicine
- Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma
- (2020) Fabien Robin et al. BRITISH JOURNAL OF CANCER
- Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions
- (2020) A. Bararia et al. Hepatobiliary & Pancreatic Diseases International
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Identifying potential DNA methylation markers in early-stage colorectal Cancer
- (2020) Xiaoyu Zhang et al. GENOMICS
- Early Diagnosis of Pancreatic Cancer: The Key for Survival
- (2020) Gina Gheorghe et al. Diagnostics
- DNA hypomethylation-related overexpression of SFN, GORASP2 and ZYG11A is a novel prognostic biomarker for early stage lung adenocarcinoma
- (2019) Ryan Edbert Husni et al. Oncotarget
- Molecular subtypes of pancreatic cancer
- (2019) Eric A. Collisson et al. Nature Reviews Gastroenterology & Hepatology
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- The relation between PI3K/AKT signalling pathway and cancer
- (2019) Saeed Noorolyai et al. GENE
- TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells
- (2019) Jian Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Deciphering DNA methylation signatures of pancreatic cancer and pancreatitis
- (2019) Francesco Natale et al. Clinical Epigenetics
- DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
- (2019) Lukas Vrba et al. Epigenetics
- DNA Methylation Cancer Biomarkers: Translation to the Clinic
- (2019) Warwick J. Locke et al. Frontiers in Genetics
- Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker
- (2019) Vorapan Sirivatanauksorn et al. SURGICAL ONCOLOGY-OXFORD
- Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ Discovery
- (2019) Mariarita Brancaccio et al. Genes
- Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- (2018) Gwen Lomberk et al. Nature Communications
- Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer
- (2018) Maria Arechederra et al. Nature Communications
- Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma
- (2018) Tamara M.H. Gall et al. AMERICAN JOURNAL OF PATHOLOGY
- Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
- (2018) James RW Conway et al. GUT
- The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer
- (2017) Inês Faleiro et al. Future Oncology
- Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways
- (2017) Sanchari Bhattacharyya et al. GENOME RESEARCH
- Early detection of pancreatic cancer: Where are we now and where are we going?
- (2017) Bin Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Acinar cell plasticity and development of pancreatic ductal adenocarcinoma
- (2017) Peter Storz Nature Reviews Gastroenterology & Hepatology
- The Pancreatic Expression Database: 2018 update
- (2017) Jacek Marzec et al. NUCLEIC ACIDS RESEARCH
- Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma
- (2017) Pascal Syren et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
- (2017) Rémy Nicolle et al. Cell Reports
- Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis
- (2017) Jiayun Nian et al. Clinical and Translational Gastroenterology
- Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer
- (2016) Junli Guo et al. International Journal of Biological Sciences
- Genomic analyses identify molecular subtypes of pancreatic cancer
- (2016) Peter Bailey et al. NATURE
- Accumulated promoter methylation as a potential biomarker for esophageal cancer
- (2016) Xianzhen Peng et al. Oncotarget
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Implication of epigenetics in pancreas development and disease
- (2015) Evans Quilichini et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- p85α is a microRNA target and affects chemosensitivity in pancreatic cancer
- (2015) Paul A. Toste et al. JOURNAL OF SURGICAL RESEARCH
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
- (2015) Wenting Xu et al. Cell Adhesion & Migration
- Pancreatic Cancer Patient Survival Correlates with DNA Methylation of Pancreas Development Genes
- (2015) Michael J. Thompson et al. PLoS One
- Oncogenic KRAS signalling in pancreatic cancer
- (2014) S Eser et al. BRITISH JOURNAL OF CANCER
- Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling
- (2014) Katia Nones et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular pathology of pancreatic cancer
- (2014) Yuriko Saiki et al. PATHOLOGY INTERNATIONAL
- Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
- (2014) Daniel Neureiter WORLD JOURNAL OF GASTROENTEROLOGY
- A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype
- (2014) Ryan W Serra et al. eLife
- PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors
- (2013) Edward M. Wolin CANCER LETTERS
- Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer
- (2013) G. Zhang et al. CLINICAL CANCER RESEARCH
- Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
- (2013) Mitchell Cheung et al. CURRENT CANCER DRUG TARGETS
- Modification of Enhancer Chromatin: What, How, and Why?
- (2013) Eliezer Calo et al. MOLECULAR CELL
- TET enzymes, TDG and the dynamics of DNA demethylation
- (2013) Rahul M. Kohli et al. NATURE
- The pancreatic expression database: recent extensions and updates
- (2013) Abu Z. Dayem Ullah et al. NUCLEIC ACIDS RESEARCH
- Epigenetic biomarkers: A new perspective in laboratory diagnostics
- (2012) J.L. García-Giménez et al. CLINICA CHIMICA ACTA
- Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
- (2012) Jordan M. Winter et al. JOURNAL OF SURGICAL ONCOLOGY
- DNA methylation profiling in the clinic: applications and challenges
- (2012) Holger Heyn et al. NATURE REVIEWS GENETICS
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma
- (2012) Geng Zhang et al. PLoS One
- Evaluation of α2-Integrin Expression as a Biomarker for Tumor Growth Inhibition for the Investigational Integrin Inhibitor E7820 in Preclinical and Clinical Studies
- (2011) Ron J. Keizer et al. AAPS Journal
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Neuroendocrine Pancreatic Tumors: Guidelines for Management and Update
- (2011) William R. Burns et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma
- (2010) Jeran K. Stratford et al. PLOS MEDICINE
- Clinical significance of Stratifin, ERα and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients
- (2009) Sameer Mirza et al. CLINICAL BIOCHEMISTRY
- Pancreatic cancer: molecular pathogenesis and new therapeutic targets
- (2009) Han H. Wong et al. Nature Reviews Gastroenterology & Hepatology
- 14-3-3 Modulates Pancreatic Cancer Cell Survival and Invasiveness
- (2008) D. Neupane et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started